Open AccessHEALING RATE IN DIABETIC FOOT ULCERS TREATED WITH BIOMEMBRANE AND HYDROCOLLOID POWDER: RANDOMIZED CLINICAL TRIAL
Author(s) -
Manuela de Mendonça Figueirêdo Coelho,
Luciana Catunda Gomes de Menezes,
Shérida Karanini Paz de Oliveira,
Ana Débora Alcantara Coêlho Bonfim,
Viviane Mamede Vasconcelos Cavalcante,
Juliano Teixeira Moraes,
Riksberg Leite Cabral
Publication year - 2021
Publication title -
estima
Language(s) - English
Resource type - Journals
eISSN - 2595-7007
pISSN - 1806-3144
DOI - 10.30886/estima.v19.986_in
Subject(s) - diabetic foot , medicine , randomized controlled trial , clinical trial , foot (prosody) , surgery , diabetes mellitus , linguistics , philosophy , endocrinology
Objective: to evaluate the rate of healing in diabetic foot ulcers treated with a biomembrane of latex proteins from Calotropis procera (BioMem CpLP) when compared to powdered hydrocolloid. Method: randomized controlled clinical trial, registered by the Brazilian Clinical Trial Registry (REBEC), according to protocol RBR-98f3j9, carried out with eight people with diabetic foot, in a diabetic foot clinic, from March to July 2019. In the experimental group (n = 04), biomembrane was applied; in the control group (n = 04), hydrocolloid powder was used. The healing rate was assessed at 30 and 60 days after starting treatment. Results: no statistical differences were found between the healing rates of the control group and the experimental group in the temporal analysis of the initial 30 days (p = 0.726) and in the 60 days following the start of treatment (p = 0.562). Conclusion: BioMem CpLP presented healing rates similar to the conventional product, being an effective and low cost alternative for the treatment of diabetic feet.